Drug
Regv131
Regv131: highest development phase Phase 1/2, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| REGV131 NCT06379789 | Phase 1/2 | Hemophilia B |
Latest
No recent events.
Follow Regv131 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.